Mediolanum looks set for takeoff
Article Abstract:
Mediolanum SpA received a favorable rating from Standard & Poor and analysts predict its shares increasing by 25% before the end of the year.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Fiat outlines strategy for auto division, will seek opportunities for acquisitions
Article Abstract:
Fiat SpA's chief executive Paolo Cantarella said that his company's auto division is expected to be profitable again by the fourth quarter of 1999. Mr. Cantarella said that Fiat has $10 billion for investments in acquisitions or in other sectors of the group. During the first quarter of 1999, the car maker posted a 211 billion Italian lire ($115.5 million) loss. Fiat also posted an 84% drop in pretax profits for the period.
Comment:
Auto division expected to be profitable again by fourth quarter of 1999
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Intesa board says bank will buy CariPharma stake
Article Abstract:
Italy-based Banca Intesa SpA'a board agreed recently to buy the remaining 23.4% of Italy-based savings bank Cassa di Risparmio di Pharma e Placenza (CariPharma)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Mattel pursues sale of Learning Co. to end saga of troubled acquisition. Inprise and Corel agree to call off their merger plan
- Abstracts: US Navy extends work supporting sensors for littoral operations. US Navy aims to get Orion/Aries replacement under way
- Abstracts: DuPont's net income increase buoyed by Herberts acquisition. Anheuser-Busch reports 9.8% rise in its net income
- Abstracts: Lockheed Martin's earnings fell 37% for third quarter, beating forecasts. Lockheed Martin swung to a profit in first-quarter
- Abstracts: Pfizer to sell incontinence drug to defuse competition concerns. Elan shopping spree in U.S. nets Dura Pharmaceuticals